You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SKYE Sale Disclosure
Schwab Andrew J. · SEC Form 4 · Filed Sep 24, 2026
Sale
Calculated transaction value
$184.91K
Schwab Andrew J. Director / Ten Percent Owner
SKYE
Skye Bioscience
SKYE
Transaction date
Sep 23, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 1 day later
SKYE daily price context
Close on/before transaction
$1.8
Sep 23, 2026
First close after public filing
$1.67
Sep 25, 2026
30-day return after filing
-5.99%
Through Oct 26, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 114,851 shares @ $1.61
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001598549-26-000015
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$239.56K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Skye Bioscience, Inc. SKYE Current | Sale | Sep 23, 2026 | $184.91K |
| Skye Bioscience, Inc. SKYE | Sale | Sep 23, 2026 | $7.29K |
| Skye Bioscience, Inc. SKYE | Sale | Sep 22, 2026 | $1.8K |
| Skye Bioscience, Inc. SKYE | Sale | Sep 22, 2026 | $45.56K |